Olympus Corporation

OTCPK:OCPN.F Stock Report

Market Cap: US$10.6b

Olympus Past Earnings Performance

Past criteria checks 1/6

Olympus's earnings have been declining at an average annual rate of -0.4%, while the Medical Equipment industry saw earnings growing at 10.6% annually. Revenues have been growing at an average rate of 5.8% per year. Olympus's return on equity is 11%, and it has net margins of 8.6%.

Key information

-0.35%

Earnings growth rate

2.88%

EPS growth rate

Medical Equipment Industry Growth8.90%
Revenue growth rate5.78%
Return on equity10.97%
Net Margin8.59%
Next Earnings Update12 May 2026

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Olympus makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OTCPK:OCPN.F Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 25987,50684,800500,3140
30 Sep 25977,65397,724465,4280
30 Jun 25969,023112,005498,9030
31 Mar 25997,332117,800461,2440
31 Dec 24985,71795,841495,3000
30 Sep 24973,59587,726454,2120
30 Jun 24966,04627,884484,9630
31 Mar 24936,21026,610437,9380
31 Dec 23916,09239,468421,2180
30 Sep 23901,50756,534409,4940
30 Jun 23875,586126,381386,2530
31 Mar 23881,923137,809386,3960
31 Dec 22933,645137,623406,5370
30 Sep 22925,858126,848435,0040
30 Jun 22891,410121,912384,3220
31 Mar 22868,867115,742371,2060
31 Dec 21793,72795,274346,9760
30 Sep 21774,11398,063363,4240
30 Jun 21785,41184,467340,9540
31 Mar 21730,54465,599325,4890
31 Dec 20715,92446,443357,9250
30 Sep 20724,72241,459331,4370
30 Jun 20752,17642,855345,9490
31 Mar 20797,41151,670366,6910
31 Dec 19807,88760,758381,4690
30 Sep 19801,20249,704391,9690
30 Jun 19795,19333,469403,7070
31 Mar 19793,8628,147407,6440
31 Dec 18795,47915,554409,5250
30 Sep 18798,91521,732406,0660
30 Jun 18795,20530,324402,7080
31 Mar 18786,49757,064397,2230
31 Dec 17786,60885,083346,19439,784
30 Sep 17767,50885,830340,12339,784
30 Jun 17751,45879,716333,32139,784
31 Mar 17748,05078,191334,99339,784
31 Dec 16745,54360,888327,51041,753
30 Sep 16758,77748,983334,31741,753
30 Jun 16785,44454,390345,22641,753
31 Mar 16804,57862,594348,60341,753
31 Dec 15807,1972,188354,99035,697
30 Sep 15805,4324,742348,95435,697
30 Jun 15785,230-144336,47735,697

Quality Earnings: OCPN.F has high quality earnings.

Growing Profit Margin: OCPN.F's current net profit margins (8.6%) are lower than last year (9.7%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: OCPN.F's earnings have declined by 0.4% per year over the past 5 years.

Accelerating Growth: OCPN.F's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: OCPN.F had negative earnings growth (-11.5%) over the past year, making it difficult to compare to the Medical Equipment industry average (7.5%).

Return on Equity

High ROE: OCPN.F's Return on Equity (11%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/14 10:49
End of Day Share Price 2026/04/09 00:00
Earnings2025/12/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Olympus Corporation is covered by 27 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Warren LauAletheia Analyst Network Limited
Masahiro NakanomyoBarclays
Ritsuo WatanabeBofA Global Research